查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1960055

血液加溫器市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、最終用戶、地區和競爭對手分類，2021-2031年

Blood Warmer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血液加溫器市場預計將從 2025 年的 17.1 億美元成長到 2031 年的 23.6 億美元，複合年成長率為 5.52%。

這些專用醫療設備對於在輸注前將靜脈輸液和血液製品加熱至體溫至關重要，可顯著降低大型手術和創傷治療期間發生低體溫的風險。推動這一市場成長的根本因素包括：複雜外科手術數量的增加、需要大量輸血的慢性疾病盛行率的上升，以及基於嚴格的臨床通訊協定對患者進行精準體溫管理以提高術後復健率的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 17.1億美元
市場規模：2031年 23.6億美元
複合年成長率：2026-2031年 5.52%
成長最快的細分市場 非攜帶式血液/靜脈輸液加溫器
最大的市場 北美洲

根據美國癌症協會預測，2024年美國新增癌症病例將首次超過200萬例。這項數據凸顯了對外科手術和輔助技術（例如熱療系統）日益成長的需求。然而，由於先進熱療設備及其專用一次性耗材的初始成本和營運成本較高，市場面臨嚴峻的挑戰。這些經濟限制可能會阻礙小規模醫療機構和預算有限的發展中地區採用這些設備，從而限制其市場滲透率，儘管其臨床療效顯著。

市場促進因素

創傷和急診病例的增加是推動血液溫度監測系統應用的主要動力，尤其是在院前急救和急診室環境中。嚴重創傷通常需要大量通訊協定，而快速輸注低溫液體可能導致“創傷死亡三聯徵”，即體溫過低、凝血功能障礙和酸中毒。因此，急救服務和創傷中心擴大採用高流量熱療設備，以在救命治療期間穩定患者的核心體溫。根據美國國家公路交通安全管理局 (NHTSA) 2024 年 4 月的報告顯示，2023 年美國約有 40,990 人死於交通事故，這凸顯了交通事故創傷帶來的沉重負擔，這些創傷需要即時複雜的醫療干預，包括液體復甦。

同時，軍方和國防部門日益成長的需求正在加速研發和採購專為惡劣環境設計的攜帶式、堅固耐用的血液熱療解決方案。國防機構正優先推進戰場醫療技術的發展，以提高遭受出血性休克的戰鬥傷者的生存率，這就需要輕便的電池供電設備。這一戰略重點得到了大量資金的支持。根據斯德哥爾摩國際和平研究所（SIPRI）2024年4月發布的報告，2023年全球軍費開支成長了6.8%，達到創紀錄的2.443兆美元，從而能夠擴大戰場醫療設備的採購。這項軍事措施與更廣泛的民用血液製品需求相輔相成。正如美國紅十字會在2024年指出的那樣，美國每兩秒鐘就有人需要輸血或血小板，這凸顯了在頻繁輸血過程中有效控制體溫的普遍必要性。

市場挑戰

先進血液療法設備及其專用一次性耗材的高昂購買和營運成本是全球血液療法市場擴張的主要障礙。儘管其臨床益處已得到充分證實，但採購這些設備的經濟負擔令採購部門猶豫不決，尤其是在資金有限的小規模區域醫院和發展中地區。每次輸血都需要一套專用的一次性耗材，加劇了這個問題。一次性資本支出轉化為持續的營運成本，迫使許多醫療機構為了維持短期現金流而繼續使用過時的系統，從而延緩了升級到更新、更有效率的血液療法技術。

這種經濟壓力直接阻礙了市場成長，因為它將目標市場限制在資金雄厚的醫療機構。隨著醫院營運利潤率的下降，輔助手術支援設備的預算撥款往往首當其衝被削減。根據美國醫院協會 (AHA) 預測，到 2024 年，醫院總支出將增加 5.1%，這成長速度遠超整體通膨率，對醫療機構預算造成沉重負擔。成本不斷上漲的環境限制了投資血液加溫設備等專業技術所需的財務柔軟性，導致市場滲透率停滯不前，儘管手術量增加，但整體銷售額卻出現下滑。

市場趨勢

智慧連接和物聯網功能的融合正在重塑市場格局。隨著醫療機構將無縫資料互通性和自動化記錄列為優先事項，現代血液加溫系統擴大採用無線模組。這使得溫度資料能夠即時傳輸到電子健康記錄 (EHR) 系統，從而確保嚴格遵守臨床文件標準。這種數位化不僅減輕了護理人員的行政負擔，而且透過實現對輸液參數的持續遠端監測，提高了病患安全。歐洲心血管研究所 (ECRI) 於 2024 年 12 月發布的《2025 年安全優先事項》也支持這一趨勢，該報告強調了人工智慧醫療技術在臨床環境中的重要性。

同時，隨著消除交叉感染和簡化醫院工作流程的迫切需求，市場正經歷著向一次性熱敏套裝的重大轉變。醫療機構傾向於採用乾熱技術，該技術使用無菌的、患者專用的盒式裝置和導管，無需在手術間隙進行耗時的消毒程序。這種對高週轉率耗材的偏好，在嚴格遵守感染控制通訊協定的同時，也提高了高容量手術中心的運作效率。這種對耗材主導醫療解決方案的需求，正在推動主要製造商的財務成長。例如，Solventum公司報告稱，其2025年8月的總銷售額成長了3.9%，其中，受強勁的手術耗材需求驅動，醫療外科業務成為成長的主要動力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血液加溫器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（攜帶式血液/輸液加溫器，非攜帶式血液/輸液加溫器）
    • 按應用領域（外科手術、急診、新生兒護理、居家醫療等）
    • 依最終用戶（醫院/診所、門診服務機構、國防機構、救援機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血液加溫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血液加溫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血液加溫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血液加溫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美血液加溫器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球血液加溫器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Stryker Corporation
  • Gentherm Medical, LLC
  • Belmont Instrument, LLC
  • 3M Company
  • ICU Medical, Inc.
  • Vyaire Medical, Inc.
  • The Surgical Company Holding BV
  • Life Warmer Inc.
  • Estill Medical Technologies, Inc.
  • Smisson-Cartledge Biomedical, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24000

The Global Blood Warmer Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to USD 2.36 Billion by 2031, advancing at a CAGR of 5.52%. These specialized medical devices are essential for heating intravenous fluids and blood products to body temperature before transfusion, thereby significantly reducing the risk of hypothermia during major surgeries or trauma care. This market growth is fundamentally underpinned by the rising volume of complex surgical procedures and the increasing prevalence of chronic conditions requiring massive transfusions, alongside strict clinical protocols that mandate precise patient temperature management to enhance post-operative recovery rates.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.71 Billion
Market Size 2031USD 2.36 Billion
CAGR 2026-20315.52%
Fastest Growing SegmentNon-portable Blood/IV Warmers
Largest MarketNorth America

According to the American Cancer Society, the number of new cancer diagnoses in the United States surpassed 2 million for the first time in 2024, a statistic that highlights the escalating need for surgical interventions and supportive technologies such as blood warming systems. However, the market faces a substantial challenge regarding the high acquisition and operational costs linked to advanced warming units and their proprietary disposables. These financial constraints can deter adoption in smaller healthcare facilities or developing regions where budget allocations for auxiliary surgical devices are limited, potentially restricting broader market penetration despite the evident clinical benefits.

Market Driver

The rising incidence of trauma and emergency cases serves as a primary driver for the adoption of blood warming systems, particularly within prehospital and emergency room environments. Severe injuries often necessitate massive transfusion protocols where the rapid administration of cold fluids can trigger the trauma triad of death-comprising hypothermia, coagulopathy, and acidosis-prompting emergency services and trauma centers to integrate high-flow warming devices to stabilize patient core temperatures during critical resuscitation. As reported by the National Highway Traffic Safety Administration in April 2024, an estimated 40,990 individuals died in motor vehicle traffic crashes in the United States in 2023, a figure that underscores the significant burden of vehicular trauma requiring immediate and complex medical intervention involving fluid resuscitation.

Simultaneously, increasing demand from the military and defense sectors is accelerating the development and procurement of portable, ruggedized blood warming solutions tailored for austere environments. Defense organizations are prioritizing advancements in field medical care to improve survival rates for combat casualties suffering from hemorrhagic shock, creating a need for lightweight, battery-operated equipment. This strategic focus is supported by substantial financial commitments; according to the Stockholm International Peace Research Institute's April 2024 report, global military spending rose by 6.8 percent to reach a historic high of $2443 billion in 2023, facilitating increased procurement of field medical gear. This military initiative complements the broader civilian need for blood products, as the American Red Cross noted in 2024 that someone in the United States requires blood or platelets every two seconds, highlighting the universal necessity for effective temperature management during frequent transfusions.

Market Challenge

The significant acquisition and operational costs associated with advanced blood warming units and their proprietary disposables act as a major barrier to the broader expansion of the Global Blood Warmer Market. Although the clinical benefits are well-established, the financial burden of procuring these devices creates hesitation among procurement departments, particularly in smaller community hospitals and developing regions where capital is limited. The requirement for specialized, single-use disposable sets for each transfusion exacerbates this issue by converting a one-time capital expense into a perpetual operational cost, compelling many healthcare facilities to defer upgrading to newer, more efficient warming technologies in favor of retaining legacy systems to preserve short-term cash flow.

This economic pressure directly inhibits market growth by restricting the addressable market to only the most well-funded institutions. When hospitals face shrinking operating margins, budget allocations for auxiliary surgical support devices are often the first to be reduced. According to the American Hospital Association, total hospital expenses increased by 5.1% in 2024, a rate that significantly outpaced overall inflation and placed immense strain on facility budgets. This escalating cost environment limits the fiscal flexibility required to invest in specialized technologies like blood warmers, thereby stalling market penetration and reducing the overall volume of unit sales despite the rising volume of surgical procedures.

Market Trends

The integration of Smart Connectivity and IoT Capabilities is reshaping the market as healthcare providers prioritize devices that offer seamless data interoperability and automated record-keeping. Modern blood warming systems are increasingly equipped with wireless modules that allow for the real-time transmission of temperature data directly to electronic health records (EHR), ensuring strict compliance with clinical documentation standards. This digitization reduces administrative burdens on nursing staff and enhances patient safety by enabling continuous remote monitoring of infusion parameters, a trend underscored by ECRI in December 2024, which identified the deployment of AI-enabled health technologies as the top safety focus for 2025, reflecting the critical volume of smart, connected devices entering the clinical environment.

Concurrently, the market is experiencing a decisive shift toward single-use disposable warming sets, driven by the imperative to eliminate cross-contamination and streamline hospital workflows. Healthcare facilities are favoring dry-heat technologies that utilize sterile, patient-specific cassettes and tubing, thereby negating the need for time-consuming sterilization procedures between cases. This preference for high-turnover consumables promotes operational efficiency in high-throughput surgical centers while adhering to rigorous infection prevention protocols. This demand for consumable-driven medical solutions is fueling financial growth for key manufacturers; for instance, Solventum reported a 3.9% increase in total sales in August 2025, with its MedSurg segment cited as a primary contributor to this growth driven by robust demand for surgical supplies.

Key Market Players

  • Stryker Corporation
  • Gentherm Medical, LLC
  • Belmont Instrument, LLC
  • 3M Company
  • ICU Medical, Inc.
  • Vyaire Medical, Inc.
  • The Surgical Company Holding B.V.
  • Life Warmer Inc.
  • Estill Medical Technologies, Inc.
  • Smisson-Cartledge Biomedical, LLC

Report Scope

In this report, the Global Blood Warmer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Warmer Market, By Product

  • Portable Blood/IV Warmers Device
  • Non-portable Blood/IV Warmers

Blood Warmer Market, By Application

  • Surgery
  • Acute Care
  • New Born Care
  • Homecare
  • Others

Blood Warmer Market, By End User

  • Hospitals/Clinic
  • Ambulatory Services
  • Defense Forces
  • Rescue Forces

Blood Warmer Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Warmer Market.

Available Customizations:

Global Blood Warmer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Warmer Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Portable Blood/IV Warmers Device, Non-portable Blood/IV Warmers)
    • 5.2.2. By Application (Surgery, Acute Care, New Born Care, Homecare, Others)
    • 5.2.3. By End User (Hospitals/Clinic, Ambulatory Services, Defense Forces, Rescue Forces)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Blood Warmer Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Warmer Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Blood Warmer Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Blood Warmer Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Blood Warmer Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Warmer Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Blood Warmer Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Blood Warmer Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Blood Warmer Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Blood Warmer Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Blood Warmer Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Warmer Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Blood Warmer Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Blood Warmer Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Blood Warmer Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Blood Warmer Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Warmer Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Warmer Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Blood Warmer Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Blood Warmer Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Blood Warmer Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Warmer Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Blood Warmer Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Blood Warmer Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Warmer Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Stryker Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Gentherm Medical, LLC
  • 15.3. Belmont Instrument, LLC
  • 15.4. 3M Company
  • 15.5. ICU Medical, Inc.
  • 15.6. Vyaire Medical, Inc.
  • 15.7. The Surgical Company Holding B.V.
  • 15.8. Life Warmer Inc.
  • 15.9. Estill Medical Technologies, Inc.
  • 15.10. Smisson-Cartledge Biomedical, LLC

16. Strategic Recommendations

17. About Us & Disclaimer